I am a doctoral candidate specializing in Pharmaceutical Health Outcomes and Policy. My research uses data-driven approaches to optimize health interventions, primarily within the field of oncology. I have expertise in pharmacoeconomics and pharmacoepidemiology study designs and poses skills in large electronic database analyses, statistical methods, scientific writing, and grantsmanship. My interests encompass evaluating clinical, economic, and humanistic outcomes of novel therapeutic interventions and addressing health disparities. Currently, my research focuses on assessing the safety and effectiveness of cutting-edge immune-oncologic agents, particularly among diverse and vulnerable populations. My drive stems from a personal experience of the transformative impact of medicine and health policies, fueling my mission to bridge the gap between research and meaningful improvements in patient-centered care.